Physiological Health Monitoring and Performance
This capability encompasses real-time capture and interpretation of vital signs, ECG, respiratory patterns, continuous hemodynamics, tissue oxygenation, and biochemical markers using wearable sensors, implantables, and remote platforms. Predictive analytics and decision-support enable earlier detection of shock, TBI deterioration, infection, and fatigue to inform triage, prolonged-field care, and readiness.
Technical Challenges
Reliable continuous monitoring in austere, high-motion, and high-noise battlefield environments (motion artifact, signal loss).
Interoperability across heterogeneous sensors, vehicle/medic systems, and electronic health records under constrained bandwidth.
Rapid, validated algorithms that generalize across diverse physiologies and polytrauma patterns without unacceptable false alarms.
Biocompatibility and power constraints for implantable/long-duration wearable devices in prolonged-field-care scenarios.
Emerging Opportunities
Low-power, secure edge analytics that provide actionable alerts when evacuation is delayed.
Validated multi-parameter biomarkers and thresholds for early hemorrhagic shock, sepsis, and TBI progression in tactical populations.
Standardized data formats and secure, resilient networks to transmit monitoring data during degraded communications.
Miniaturized continuous biochemical sensors (e.g., lactate, electrolytes) that function reliably in sweat/blood matrices.
Current and Emerging Technologies in Physiological Health Monitoring and Performance
Wearable biosensors and multimodal patches
Flexible ECG/PPG/accelerometer patches and adhesive multimodal sensors capture continuous heart rate, rhythm, SpO2, respiration, and activity with better ergonomics for prolonged wear.
Continuous hemodynamic and tissue oxygenation monitors
Noninvasive or minimally invasive monitors (NIRS, Doppler, cuffless blood pressure) detect early hypoperfusion, enabling recognition of compensated shock before collapse.
Point-of-care biochemical microfluidics
Miniaturized assays and continuous lactate, electrolyte, and biomarker sensors support diagnosis of metabolic derangements, sepsis, and exertional injury at the point of need.
Implantable and epidermal sensor platforms
Biocompatible implants and long-duration epidermal systems enable monitoring after traumatic injuries and during prolonged field care when external wearables may be removed or damaged.
AI-driven predictive analytics and decision support
Machine learning models fuse multimodal signals to predict deterioration, prioritize interventions, reduce false alarms, and provide actionable guidance for medics in prolonged and distributed care.
Edge computing, secure comms, and telehealth integration
Resilient, low-latency edge processing and hardened data links enable monitoring and remote clinician consultation despite limited bandwidth and contested networks.
Importance to Military Medicine
Improved combat casualty outcomes
Early detection of hemorrhage, shock, and respiratory compromise reduces time-to-intervention and mortality on the battlefield.
Enables prolonged and distributed care
Continuous monitoring supports medics and clinicians when evacuation is delayed, guiding triage, resuscitation, and resource allocation.
Maintains force readiness and resilience
Objective physiologic metrics inform fatigue management, infectious-disease surveillance, and return-to-duty decisions.
Supports austere-environment care standards
Robust monitoring tailored for extreme environments reduces diagnostic uncertainty in polytrauma, blast injuries, and prolonged-field scenarios.
Alignment with the MTEC Mission
Accelerates transition of validated monitoring technologies from lab to battlefield through DoD-focused collaborations, consistent with MTEC’s mandate to field force-relevant medical innovations faster.
Supports cross-disciplinary projects spanning combat casualty care, prolonged and distributed care, neuropsychological performance, and infectious disease—areas prioritized by MTEC.
Enables strong public–private partnerships to validate devices and analytics in operationally relevant environments, accelerating adoption and regulatory readiness.
Dual-Use (Military + Civilian) Applications
Military: battlefield triage, remote casualty monitoring, prolonged-field-care decision support, readiness surveillance, and TBI monitoring.
Civilian: emergency medicine, prehospital care, chronic disease telemonitoring, sports performance optimization, and epidemic surveillance.
Dual-use benefits accelerate regulatory pathways and commercial scale while ensuring ruggedization and security required for defense use.
Shared datasets and validation studies across military and civilian systems improve algorithm robustness and clinical generalizability.
Explore MTEC Members with Physiological Health Monitoring and Performance Capabilities
MTEC members bring cross-sector strengths—device engineering, clinical trials, regulatory expertise, and field validation—to accelerate operational deployment of physiologic monitoring.
Consortium collaboration enables rapid prototyping, access to DoD clinical partners for realistic testing, and pathways for dual-use commercialization.
Explore member profiles to find partners with expertise in biosensors, AI, telemedicine, biocompatible materials, and operational testing that advance this critical capability.
173 Members with Physiological Health Monitoring and Performance capabilities.
SIMETRI is a woman-and-minority owned small business based in Winter Park, Florida, specializing in modeling, simulation, and training technologies. Founded in 2009, the company focuses on delivering innovative products and services that enhance the human experience and improve client outcomes through advanced training and program management analysis.
IQVIA is a global leader in advanced analytics, technology solutions, and clinical research services for the life sciences industry. With a mission to accelerate innovation for a healthier world and a vision to power smarter healthcare for everyone, everywhere, IQVIA leverages unparalleled data, transformative technology, and deep healthcare expertise to drive better patient outcomes. Operating in over 100 countries with approximately 88,000 employees, IQVIA supports pharmaceutical, biotech, medtech, public health, and government organizations with a comprehensive portfolio of services and solutions. The company is recognized for its Connected Intelligence™, healthcare-grade AI, and commitment to sustainability, innovation, and evidence-based insights that shape the future of healthcare globally. IQVIA is also dedicated to reducing health inequities and driving sustainable change through innovation, collaboration, and data-driven solutions, partnering with organizations worldwide to address complex healthcare challenges.
Astrapi Corporation is a leader in revolutionary communication methods, specifically through spiral-based modulation. One capability is the Astrapi Spectrum Analyzer which enables an extremely precise method to measure continuously varying signal power which includes brain waves. This innovative technology is set to transform the next generation of communications by enhancing spectral efficiency and providing new ways to combat channel impairments. Astrapi's technology supports performance advances across various communications networks, including cellular, satellite, and defense communications, among others. Important medical applications of the Astrapi Spectrum Analyzer may include: 1. brain disorder diagnostics and measurement; 2. tumor localization; 3. enhanced prosthetics; and 4. brain-computer interfaces. Astrapi is in the process of spinning out a medical company to focus specifically on the medical applications of its Spectrum Analyzer. We welcome investors and collaborators. Our business model is to license to companies already in the medical field.
Founded in 1960 by Dr. Joseph V. Brady, the Institutes for Behavior Resources, Inc. (IBR) is a nonprofit organization dedicated to enhancing the growth of behavioral sciences and their application to human affairs through research, clinical services, and educational initiatives. IBR focuses on addressing social challenges through innovative research and comprehensive health services.
LumenAstra, Inc. is at the forefront of developing innovative, wearable, non-invasive sensors for accurately measuring internal body temperatures. Originating from a need identified by DARPA to protect troops from heat stress, the company collaborates with the University of Colorado's Radio Frequency Lab to commercialize a patented technology. This technology, initially used for astronomical measurements, is now being adapted to monitor critical health parameters such as brain and tumor temperatures, promising to revolutionize medical monitoring and treatment.
Humanetics Corporation is a clinical-stage pharmaceutical company based in Minneapolis, Minnesota, focused on developing and commercializing products to enhance human health and wellbeing. Founded in 1988, the company specializes in radiation modulators, adjunctive oncology therapies, and pulmonary protective therapies, particularly for COVID-19. Humanetics is known for its lead drug candidate, BIO 300, which is being developed as a radioprotectant for military and civilian use, as well as a treatment to improve outcomes in cancer patients receiving radiotherapy. The company is actively engaged in research programs for non-small cell lung cancer, prostate cancer, and head and neck cancers.
Physical Sciences Inc. (PSI) is an employee-owned company dedicated to inventing, demonstrating, and translating technologies that address critical national needs in defense, security, healthcare, and environmental stewardship. With over 50 years of experience, PSI combines extensive research and development capabilities with a commitment to innovation and customer focus.
Pradazka, by Integrative Mechanical Medical Devices LLC, is dedicated to revolutionizing in-patient care through innovative wireless and continuous patient monitoring technology. Their mission is to empower patients and healthcare professionals with advanced, AI-driven wearable devices that enable continuous tracking of vital signs, enhancing patient mobility, safety, and care outcomes. The company is committed to driving progress in digital health and seeks partnerships and funding to further its impact on healthcare.
Aware Custom Biometric Wearables, is a leading innovator in cutting-edge in-ear technology, specializing in superior custom hearing protection solutions and biometric hearables. Our groundbreaking in-ear solutions feature enhanced hearing capabilities, continuous monitoring, and the collection of medical-grade biometric data, all designed to enhance human performance and safeguard lives. Our commitment to innovation is reflected in our meticulously crafted in-ear devices. Thanks to our patented 3D Ear Scanner technology, we provide a custom fit tailored to the unique shape of each individual's ear which optimizes the performance of sensors. Aware is transforming the ear into a dynamic platform for health and human performance by collecting medical-grade data, delivering actionable AI-driven insights, and enabling precision therapeutics within devices we wear in our everyday lives. Our technology serves a diverse range of sectors within healthcare, military, and industrial. Proudly U.S.-based, offices in Atlanta, GA and San Diego, CA. www.AwareCBW.com.
Auburn University Research & Economic Development is dedicated to advancing research and economic growth through a collaborative effort among its various colleges and departments. The organization focuses on fostering innovation, supporting faculty and student research, and facilitating partnerships with industry and government to address societal challenges and enhance the quality of life. Recent initiatives include the launch of the Team Science Series to promote interdisciplinary collaboration and the development of the Gulf Coast Engineering Research Station to address coastal environmental challenges.
Vocxi Health is a diagnostic start-up focused on early disease detection through its innovative MyBreathPrint® system. This noninvasive technology allows for immediate health assessments by analyzing volatile organic compounds (VOCs) in a patient's breath, aiming to revolutionize patient care and improve health outcomes.
Ethos Solutions specializes in rapid problem solving in dynamic environments through the Ethos IDEALs (Identification, Define, Engagement, Alignment, and Leveraging). Ethos leverages module working groups (or cells) consisting of Subject Matter Expert (SMEs) clinicians, training cadre, warriors, academics, and researchers able to rapidly identify and solve problem sets that require a grounded approach forged in austere and dynamic environments.
cosinuss° is a medical technology company based in Munich, Germany, that is pioneering an ultralight monitoring solution in Europe for situations and use cases where the currently available monitoring solutions fail. The company specializes in in-ear biosensor technology connected to mobile devices for local application, and/or additional cloud-based analytics, supporting real-time local and remote patient monitoring for medical care in challenging operations, in remote environments, clinical trials, remote patient monitoring, and telemedicine. The solution is currently only available for sale in Europe.
Zeteo Tech is a venture-backed biodefense and medical device company that has developed a revolutionary new class of fieldable biological mass spectrometers. Their technology identifies airborne microbes, proteins, and lipids, enabling rapid screening for infectious diseases and bio-threats. With a focus on cost-effective solutions, Zeteo Tech aims to enhance biodefense capabilities and improve patient screening for diseases like tuberculosis.
Waverly Technology is a women-owned, service-disabled veteran-owned small business specializing in IT solutions, cybersecurity, professional development, and innovative health technology. The company provides consulting, project management, and cloud computing services, with a focus on continuous learning, mentoring, and training programs for leaders, youth, active military, and veterans. Waverly is also developing e-textile solutions for remote cardiac monitoring, aiming to enable early detection of arrhythmias and improve patient outcomes.
CranioSense, Inc. is a clinical stage medical device company developing a non invasive technology designed to support rapid assessment of intracranial hypertension at the point of care. Built for use by emergency care teams, the system integrates into the triage workflow, providing a quick and low risk screening tool to help identify patients who may require further diagnostic evaluation. By delivering actionable information within minutes without the need for invasive procedures or specialized expertise, CranioSense aims to improve triage, accelerate clinical decision making, and enhance patient outcomes in time critical neurological care.

Safi Biotherapeutics
Next-Generation Manufactured Red Blood Cells for Extended Battlefield Blood Supply: Safi Biotherapeutics
Safi Biotherapeutics is developing manufactured red blood cells (mRBCs) with extended shelf life to improve battlefield transfusion readiness and emergency trauma care.
Non-Invasive Glymphatic (GF) Monitoring and Recovery Optimization for Warfighter Cognitive Readiness
Applied Cognition is developing non-invasive glymphatic monitoring and recovery technologies to enhance warfighter cognitive readiness, resilience, and sleep recovery.
Moberg Analytics
Moberg Analytics – Advanced Brain Monitoring & Critical Care Informatic
Moberg’s platform unifies brain monitoring data for faster, precise treatment of severe brain injuries in military and civilian care.
University of California San Francisco
TemPredict: AI-Driven Wearable Monitoring for Early Illness Detection and Warfighter Readiness
TemPredict: AI wearables detect early illness and health risks to support warfighter readiness.